Akoya Biosciences Inc (AKYA)
2.62
-0.11
(-4.03%)
USD |
NASDAQ |
Nov 04, 16:00
2.62
0.00 (0.00%)
After-Hours: 20:00
Akoya Biosciences Research and Development Expense (TTM): 20.68M for June 30, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2024 | 20.68M |
| March 31, 2024 | 22.32M |
| December 31, 2023 | 23.14M |
| September 30, 2023 | 24.91M |
| June 30, 2023 | 25.20M |
| March 31, 2023 | 23.88M |
| December 31, 2022 | 23.21M |
| September 30, 2022 | 22.34M |
| Date | Value |
|---|---|
| June 30, 2022 | 20.87M |
| March 31, 2022 | 18.22M |
| December 31, 2021 | 15.70M |
| September 30, 2021 | 12.67M |
| June 30, 2021 | 10.95M |
| March 31, 2021 | 10.42M |
| December 31, 2020 | 9.603M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
9.603M
Minimum
Dec 2020
25.20M
Maximum
Jun 2023
18.94M
Average
20.87M
Median
Jun 2022
Research and Development Expense (TTM) Benchmarks
| Bruker Corp | 328.80M |
| Azenta Inc | 34.04M |
| Harvard Bioscience Inc | 11.42M |
| Bionano Genomics Inc | 42.10M |
| Singular Genomics Systems Inc | 45.13M |